联合王国卫生官员建议采用新的树花粉过敏治疗,即ITULAZAX,供国家保健服务使用。 UK health officials recommend new tree pollen allergy treatment, ITULAZAX®, for NHS use.

联合王国国家保健和护理英才研究所(NICE)建议在英格兰、威尔士和北爱尔兰使用ALK的树花粉片ITOLLAZAX,供NHS使用。 The UK's National Institute for Health and Care Excellence (NICE) has recommended ALK's tree pollen tablet, ITULAZAX®, for NHS use in England, Wales, and Northern Ireland. 这项建议使约27 000名无节制的树花粉过敏者能够获得治疗,通过训练免疫系统在三年内容忍树花粉,提供长期救济。 This recommendation makes the treatment accessible to about 27,000 people with uncontrolled tree pollen allergy, offering long-term relief by training the immune system to tolerate tree pollen over three years. NICE预计将在8月公布最后指南,之后将要求国民保健制度执行平板。 NICE expects to publish final guidance in August, after which the NHS will be required to implement the tablet.